Skip to main content

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC

Position in FLGT — Fulgent Genetics, Inc.

CIK 861177 NEW YORK, NY

Position in FLGT

as of Mar 31, 2026 · filed May 13, 2026
Position Value
$1,610,717
-$1,024,057 QoQ
Shares Held
101,303
+1.0% QoQ
Ownership
0.357%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2020
22 quarters on record
Voting authority Sole 68.56065466965441.ToString("F0")% Shared 0.ToString("F0")% None 31.439345330345596.ToString("F0")%

Common Shares in FLGT Over Time

Shares Held

Position Value (USD)

Position in Diagnostics & Research

Healthcare · as of Mar 31, 2026

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $4,972,110,878 across 32 Diagnostics & Research names. FLGT ranks #27 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in FLGT

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $1,610,717 101,303
2025-12-31 $2,634,774 100,296
2025-09-30 $1,295,949 57,343
2025-06-30 $2,024,537 101,838
2025-03-31 $1,133,244 67,056
2024-12-31 $935,576 50,654
2024-09-30 $970,632 44,668
2024-06-30 $760,664 38,770
2024-03-31 $509,274 23,469
2023-12-31 $583,517 20,184
2023-09-30 $539,718 20,184
2023-06-30 $675,388 18,239
2023-03-31 $569,419 18,239
2022-12-31 $693,753 23,296
2022-09-30 $789,997 20,724
2022-06-30 $1,170,703 21,469
2022-03-31 $1,615,479 25,885
2021-12-31 $2,580,534 25,654
2021-09-30 $1,797,648 19,985
2021-06-30 $2,224,494 24,119
2021-03-31 $2,035,107 21,063
2020-12-31 $1,104,520 21,200